Literature DB >> 1541540

Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

C A Bate1, J Taverne, N D Karunaweera, K N Mendis, D Kwiatkowski, J H Playfair.   

Abstract

Exoantigens of Plasmodium vivax-parasitized erythrocytes stimulated macrophages to secrete tumor necrosis factor, and antisera raised against the exoantigens inhibited this secretion. The antisera also inhibited the activity of Plasmodium falciparum and Plasmodium yoelii exoantigens, and conversely, antisera against the latter cross-reacted with the exoantigens of P. vivax.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1541540      PMCID： PMC257621          DOI： 10.1128/iai.60.3.1241-1243.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum.

Authors:  S Picot; F Peyron; J P Vuillez; G Barbe; K Marsh; P Ambroise-Thomas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Authors:  J Taverne; C A Bate; D Kwiatkowski; P H Jakobsen; J H Playfair
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum.

Authors:  J Taverne; C A Bate; D A Sarkar; A Meager; G A Rook; J H Playfair
Journal:  Parasite Immunol       Date:  1990-01       Impact factor: 2.280

Review 4.  Anti-parasite effects of cytokines in malaria.

Authors:  K N Mendis; T D Naotunne; N D Karunaweera; G Del Giudice; G E Grau; R Carter
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

5.  Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands.

Authors:  G A Butcher; T Garland; A B Ajdukiewicz; I A Clark
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

6.  Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody.

Authors:  J Taverne; C A Bate; J H Playfair
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

7.  Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Authors:  C A Bate; J Taverne; E Román; C Moreno; J H Playfair
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Cell-mediated immunity in protection and pathology of malaria.

Authors:  I A Clark
Journal:  Parasitol Today       Date:  1987-10

9.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

10.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397
View more
  10 in total

1.  Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.

Authors:  N A Sheikh; H N Caro; J Taverne; J H Playfair; T W Rademacher
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 2.  Multispecies Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1999-02       Impact factor: 1.276

3.  Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria.

Authors:  P G Kremsner; A Nüssler; S Neifer; M F Chaves; U Bienzle; G Senaldi; G E Grau
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

6.  Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults.

Authors:  Craig S Boutlis; D Channe Gowda; Ramachandra S Naik; Graeme P Maguire; Charles S Mgone; Moses J Bockarie; Moses Lagog; Erwin Ibam; Kerry Lorry; Nicholas M Anstey
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.

Authors:  P H Jakobsen; S Morris-Jones; A Rønn; L Hviid; T G Theander; I M Elhassan; I C Bygbjerg; B M Greenwood
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

8.  Phospholipids coupled to a carrier induce IgG antibody that blocks tumour necrosis factor induction by toxic malaria antigens.

Authors:  C A Bate; J Taverne; D Kwiatkowski; J H Playfair
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline, and tumor necrosis factor secretion is reduced.

Authors:  J Prada; C Prager; S Neifer; U Bienzle; P G Kremsner
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria.

Authors:  K Willimann; H Matile; N A Weiss; B A Imhof
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.